Healing Peptides: The Complete Evidence-Based Guide
Everything researchers and self-experimenters need to know about peptides used for tissue repair, injury recovery, and inflammation — backed by real studies.
Key Takeaway
Healing peptides like BPC-157 and TB-500 have promising preclinical data for tissue repair, but human clinical trials are limited. This guide covers what the research actually shows, proper dosing protocols, and important safety considerations.
The Most Researched Healing Peptides
BPC-157 (Body Protection Compound)
BPC-157 is a 15-amino-acid peptide derived from a protein found in gastric juice. With over 100 published studies, it has the largest evidence base of any healing peptide. Research shows it promotes angiogenesis (new blood vessel formation), upregulates growth factor expression, and accelerates healing of tendons, ligaments, muscles, gut lining, and bone.
Most evidence comes from animal models. Human clinical data is limited but growing. A Phase 2 trial for inflammatory bowel disease was initiated in 2021.
TB-500 (Thymosin Beta-4 Fragment)
TB-500 is a synthetic fragment of thymosin beta-4, a naturally occurring protein involved in cell migration, differentiation, and tissue repair. It works systemically rather than locally, making it popular for injuries in multiple areas.
Research shows it promotes cell migration to injury sites, reduces inflammation, and supports new blood vessel growth. It has been extensively studied in veterinary medicine (equine injury recovery) with limited human clinical data.
GHK-Cu (Copper Peptide)
GHK-Cu is a naturally occurring tripeptide bound to copper that declines with age. Research shows it stimulates collagen synthesis, promotes wound healing, has anti-inflammatory properties, and may support tissue remodeling. It is available in both injectable and topical forms.
BPC-157 + TB-500: The Stack
The most commonly discussed healing stack combines BPC-157 (local action, angiogenesis) with TB-500 (systemic action, cell migration). They work through different mechanisms and are often used together for injury recovery.
This combination has not been studied in clinical trials. The rationale is based on their complementary mechanisms of action and community experience. See our healing and recovery stack page for protocol details.
Evidence Classification
It is important to understand the evidence level for each compound:
- BPC-157: Extensive animal data, limited human trials. Classified as preliminary evidence for human use.
- TB-500: Animal and veterinary data, very limited human studies. Classified as preliminary evidence.
- GHK-Cu: Some human data for topical applications, limited for injectable. Classified as moderate evidence for topical, preliminary for injectable.
Safety Considerations
None of these peptides are FDA-approved for therapeutic use. Key safety points:
- No long-term human safety data exists for any healing peptide
- BPC-157 may influence blood vessel growth, which could theoretically promote tumor angiogenesis (not demonstrated in studies, but a theoretical concern)
- TB-500 has been associated with headaches, nausea, and injection site discomfort
- Source quality is critical. Request certificates of analysis (COA) from suppliers
Read our complete peptide safety guide for harm reduction protocols.
Related Compounds
Related Stacks
Helpful Tools
Frequently Asked Questions
What are healing peptides?
Healing peptides are short-chain amino acid sequences that promote tissue repair, reduce inflammation, and accelerate recovery. The most researched include BPC-157 (gastric pentadecapeptide), TB-500 (thymosin beta-4 fragment), and GHK-Cu (copper peptide). None are FDA-approved for therapeutic use in humans.
What is the most researched healing peptide?
BPC-157 has the largest body of research with over 100 published studies. Most are animal studies showing accelerated healing of tendons, ligaments, muscles, gut lining, and bone. Human clinical trial data is limited but growing.
Can you stack BPC-157 and TB-500?
Many researchers and self-experimenters combine BPC-157 and TB-500 because they work through different mechanisms. BPC-157 promotes angiogenesis and growth factor expression locally, while TB-500 acts systemically on inflammation and cell migration. Stacking is common in community protocols but has not been studied in clinical trials.
Are healing peptides FDA-approved?
How are healing peptides typically administered?
Most healing peptides are administered via subcutaneous injection near the injury site. Some (like BPC-157) are also available in oral capsule form, though bioavailability differs. GHK-Cu is commonly used topically for skin applications. Proper reconstitution with bacteriostatic water is required for injectable forms.
This content is for educational and informational purposes only. It is not medical advice. Always consult a qualified healthcare provider before starting any peptide protocol. See our full medical disclaimer.